DE69535850D1 - Enterale zusammensetzung mit ribo-nucleotiden - Google Patents

Enterale zusammensetzung mit ribo-nucleotiden

Info

Publication number
DE69535850D1
DE69535850D1 DE69535850T DE69535850T DE69535850D1 DE 69535850 D1 DE69535850 D1 DE 69535850D1 DE 69535850 T DE69535850 T DE 69535850T DE 69535850 T DE69535850 T DE 69535850T DE 69535850 D1 DE69535850 D1 DE 69535850D1
Authority
DE
Germany
Prior art keywords
formula
enteral composition
nucleotide equivalents
nucleotides
ribo nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535850T
Other languages
English (en)
Inventor
Marc Leif Masor
James Lee Leach
Bruce Edward Molitor
John Durand Benson
Jeffrey Harris Baxter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/178,685 external-priority patent/US5488039A/en
Priority claimed from US08/178,687 external-priority patent/US5492899A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69535850D1 publication Critical patent/DE69535850D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE69535850T 1994-01-10 1995-01-05 Enterale zusammensetzung mit ribo-nucleotiden Expired - Lifetime DE69535850D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/178,685 US5488039A (en) 1994-01-10 1994-01-10 Method for the production of an enteral formula containing ribo-nucleotides
US08/178,687 US5492899A (en) 1994-01-10 1994-01-10 Infant nutritional formula with ribo-nucleotides
PCT/US1995/000090 WO1995018618A2 (en) 1994-01-10 1995-01-05 Enteral formula with ribo-nucleotides

Publications (1)

Publication Number Publication Date
DE69535850D1 true DE69535850D1 (de) 2008-11-13

Family

ID=26874551

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535850T Expired - Lifetime DE69535850D1 (de) 1994-01-10 1995-01-05 Enterale zusammensetzung mit ribo-nucleotiden

Country Status (10)

Country Link
EP (1) EP0739207B1 (de)
JP (1) JP3033911B2 (de)
AT (1) ATE409483T1 (de)
AU (1) AU702304B2 (de)
CA (1) CA2180464C (de)
DE (1) DE69535850D1 (de)
DK (1) DK0739207T3 (de)
HK (1) HK1011610A1 (de)
NZ (2) NZ331481A (de)
WO (1) WO1995018618A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3976997A (en) * 1996-08-13 1998-03-06 Bristol-Myers Squibb Company Nutritional formulas supplemented with nucleotides, and processes thereof
PT1410721E (pt) 2002-10-17 2006-09-29 Suedzucker Ag Processo para a preparacao de um alimento enterico contendo isomaltulose
US8815279B2 (en) 2003-02-10 2014-08-26 University College London Baby feeding formula and system
US20050175759A1 (en) 2004-02-09 2005-08-11 Atul Singhal Newborn infant formulas and feeding methods
ES2219182B1 (es) * 2003-05-12 2005-10-01 Jose Luis Concellon Martinez Procedimiento para compensar el efecto negativo en la salud de alimentos que contienen azucar refinado.
JP4482493B2 (ja) * 2005-06-29 2010-06-16 明治飼糧株式会社 ロタウイルス感染・増殖抑制剤
PT1800675E (pt) 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
MX2010006887A (es) * 2007-12-20 2010-10-15 Abbott Lab Polvo nutricional estable.
US8361534B2 (en) * 2007-12-20 2013-01-29 Abbott Laboratories Stable nutritional powder
BR112012033422B8 (pt) 2010-06-28 2021-05-11 Nestec Sa formulação de alimentação por sonda de alimentação diária completa, seu uso e seu método de fabricação
WO2022144799A1 (en) * 2020-12-30 2022-07-07 Pharsmart S.R.L. Immunostimulating food supplement and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303692A (en) * 1978-11-22 1981-12-01 Gaull Gerald E Infant milk formula
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
FR2693876A1 (fr) * 1992-07-24 1994-01-28 Vani Complément nutritif à base de micronutriments.
US6764693B1 (en) * 1992-12-11 2004-07-20 Amaox, Ltd. Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants

Also Published As

Publication number Publication date
WO1995018618A3 (en) 1995-10-05
NZ331481A (en) 2000-02-28
DK0739207T3 (da) 2008-12-15
AU702304B2 (en) 1999-02-18
EP0739207B1 (de) 2008-10-01
ATE409483T1 (de) 2008-10-15
EP0739207A1 (de) 1996-10-30
WO1995018618A2 (en) 1995-07-13
NZ278778A (en) 1998-10-28
CA2180464C (en) 2001-08-14
JPH09501181A (ja) 1997-02-04
HK1011610A1 (en) 1999-07-16
JP3033911B2 (ja) 2000-04-17
CA2180464A1 (en) 1995-07-13
AU1522295A (en) 1995-08-01
MX9602693A (es) 1998-06-30

Similar Documents

Publication Publication Date Title
MX9602692A (es) Metodo para incrementar el sistema inmune humano.
DE69535850D1 (de) Enterale zusammensetzung mit ribo-nucleotiden
BAKER et al. Vitamin B6Requirement for Adult Men
MX9709859A (es) Inhibidores de adenosina cinasa modificados en c-4.
AU8465898A (en) Nutritional composition containing methionine
ATE246455T1 (de) Kohlenhydratmischung
AU628662B2 (en) Dietary supplement and method of minimizing effects of infection through diet
ATE220859T1 (de) Kaloriereiche ernährungszusammensetzung
AU587414B2 (en) Enteral nutritional hypoallergenic formula
AU5255086A (en) High fat, low carbohydrate enteral nutritional formula
Narumi et al. Activation and phosphorylation of carbonic anhydrase by adenosine 3′, 5′-monophosphate-dependent protein kinases
Wolfe et al. Erythromycin: mode of action
US5268365A (en) Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance
EP0334361A3 (de) Durch Acetylen, Cyan oder Allen substituierte Aristeromycin- oder Adenosin-Derivate
ES2191291T3 (es) Complejos de boro con carbohidratos y aplicaciones de los mismos.
CA2299729A1 (en) Improved infant formula and methods of improving infant stool patterns
DK0736256T3 (da) Enantiomert-berigede ernæringsmæssige energisubstrater
GB2216416A (en) Immunostimulating compositions comprising nucleobase sources
JPS5799194A (en) Sucrose mutase
Kim et al. The compents of free amino acids nucleotides and their related compounds in soypaste made from native and improved Meju and soypaste product
NZ214616A (en) Pharmaceutical compositions containing uridine-diphosphoglucose(udpg)
Wadler et al. Interferon augments the cytotoxicity of hydroxyurea without enhancing its activity against the M2 subunit of ribonucleotide reductase: effects in wild-type and resistant human colon cancer cells
Ortiz The inhibition of E. coli adenyl cyclase by ara ATP
ES8800278A1 (es) Procedimiento para la obtencion de derivados de hexosa acilados
EP0320807A3 (de) Nucleinsäure-Analoge, Verfahren zur Inhibition von Nucleinsäure-Polymerasen und Verfahren zur Induktion der Synthese von Interferon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition